Emerging Immunopharmacological Targets in Multiple Sclerosis

Journal of the Neurological Sciences - Netherlands
doi 10.1016/j.jns.2015.09.346
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

Emerging Therapies for Relapsing Multiple Sclerosis

Archives of Neurology
2009English

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Current Drug Target -Inflammation & Allergy
2004English

Review: Multiple System Atrophy: Emerging Targets for Interventional Therapies

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2016English

Interleukin-22 Is Increased in Multiple Sclerosis Patients and Targets Astrocytes

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

G Protein-Coupled Receptors as Therapeutic Targets for Multiple Sclerosis

Cell Research
Cell BiologyMolecular Biology
2012English

Emerging Small-Molecule Treatments for Multiple Sclerosis: Focus on B Cells

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Corrigendum to Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts

American Journal of Medicine
Medicine
2018English

Emerging Targets in Osteoarthritis Therapy

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2015English

Multiple Sclerosis in 2015: Managing the Complexity of Multiple Sclerosis

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy